ValCare Medical
Minimally Invasive Treatment for Valve Disease
Startup Seed Health Tech & Life Sciences Est. 2012
Total Raised
$23M
Seed
Last Round
Undisclosed
3 rounds
Investors
4
4 public
Team
3
11-50 employees
Confidence
90/100
News
6
articles
Patents
1
About
Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve and repair of the tricuspid valve. The company’s breakthrough mitral valve treatment platform is based on a D-shaped ring that serves as both a highly effective tool for mitral annulus repair and a docking station for Valcare’s exclusive replacement prosthesis.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
surgeryvalvescathetersmedical-devicesminimally-invasivecardiologysurgeonshospitalstreatments
Funding & Events
Sep 2018
Undisclosed Round $15M
Accelmed, Shanghai MicroPort CardioFlow Medtech , HBM Healthcare Investments
Nov 2023
Secondary Round Undisclosed
TechWald Holding
Jul 2012
Seed $8M
Accelmed
News (6)
Jul 2, 2024 · www.prnewswire.com
Valcare Medical, Inc. Announces Formation of Scientific Advisory Board with Renowned Mitral Valve Experts
May 13, 2024 · www.prnewswire.com
growth-positive
Valcare Medical Announces Enrollment of First Two Patients in AMEND™ TS EU Pilot Study
Customers
Apr 24, 2024 · www.prnewswire.com
growth-positive
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
InvestmentManagement Changes
Jan 27, 2021 · www.prnewswire.com
growth-positive
Valcare Medical Announces First-in-Human Transseptal Implant of the AMEND™ Annuloplasty Ring for Mitral Valve Repair
Customers
Jun 20, 2016 · www.massdevice.com
growth-positive
Valcare touts 1st-in-human use of Amend annulplasty ring
Management Changes
Jul 11, 2012 · www.globes.co.il
growth-positive
Accelmed invests $8m in US catheter co ValCare
InvestmentExpand
Details
Product Stage
Clinical Trial
Employees
11-50
Exact Count
30
District
Center District
Founded
2012
Registrar
514791656
Crunchbase
valcare-medical
Locations
Maskit 2, Herzliyya, Israel
Links
Admin
Last Update
Sep 21, 2024
Verified by
Sharon Shapira
Missing
markets, not claimed
Team (3)
Steve Sandweg
CEO
Samuel Shaolian
Founder & CTO
Founder
Nadav Yellin
General Manager